Background And Aims: In patients undergoing transurethral resection of prostate (TURP), it is vital to restrict the level of block to Tdermatome during spinal anaesthesia. Low-dose bupivacaine causes minimum haemodynamic alterations, but may provide insufficient surgical anaesthesia. Dexmedetomidine, a selective α-adrenoreceptor agonist, is a potent anti-nociceptive agent when given intrathecally. The aim of this study was to compare the adjuvant effects of intrathecal dexmedetomidine with low-dose bupivacaine spinal anaesthesia versus a higher dose of bupivacaine in patients undergoing TURP.

Methods: The study was designed as a prospective, double-blind, randomised trial that included sixty patients of American Society of Anesthesiologists Grade I-III scheduled for TURP. They were allocated into two groups: Group I receiving only hyperbaric bupivacaine intrathecally and Group II receiving dexmedetomidine with low dose bupivacaine. The time to regression of two dermatomes from the peak sensory block level was the primary outcome of the study.

Results: With comparable baseline and demographic attributes, both groups had similar peak sensory block levels (T). Patients in Group II had quicker onset with the time to reach Tbeing faster (10.72 ± 3.50 vs. 12.72 ± 3.90 min, = 0.041), longer duration of motor block (200 ± 18.23 vs. 190 ± 10.15 min, = 0.011) and increased time to first analgesic requirement (300 ± 25.30 vs. 220 ± 15.12 min, = 0.0001).

Conclusion: Intrathecal dexmedetomidine with low-dose bupivacaine provides faster onset, prolonged sensory and motor block and reduced rescue analgesic requirement in patients undergoing TURP.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752769PMC
http://dx.doi.org/10.4103/ija.IJA_324_16DOI Listing

Publication Analysis

Top Keywords

low-dose bupivacaine
16
patients undergoing
16
intrathecal dexmedetomidine
12
effects intrathecal
8
bupivacaine patients
8
undergoing transurethral
8
transurethral resection
8
resection prostate
8
spinal anaesthesia
8
dexmedetomidine low-dose
8

Similar Publications

Purpose: The C4 dermatome anesthesia holds significance for arthroscopic shoulder surgery. However, the reliability of achieving C4 dermatome anesthesia with the current low-dose ultrasound-guided interscalene block (ISB) and supraclavicular block (SCB) remains uncertain. This prospective, single-center study examined the effects of ultrasound-guided interscalene block (ISB) and supraclavicular block (SCB) on the C4 sensory dermatome in patients undergoing shoulder, hand, or wrist surgery.

View Article and Find Full Text PDF

Background: Visceral pain is common in cesarean sections conducted under combined spinal-epidural anesthesia (CSE). Epidural volume extension (EVE) is a technique for enhancing the effect of intrathecal blocks by inducing epidural fluid boluses in the CSE. Whether EVE that uses different drugs can reduce visceral pain during cesarean sections is rarely studied.

View Article and Find Full Text PDF
Article Synopsis
  • Spinal anesthesia using low-dose hypobaric mepivacaine and bupivacaine is effective for quick mobilization and same-day discharge after hip and knee surgeries.
  • Time to achieve sensory blockade was similar for both anesthetics, allowing surgeons to start operations without delays.
  • Both anesthetics provided adequate pain relief with predictable recovery times, making them suitable for fast-track orthopedic procedures.
View Article and Find Full Text PDF

Background: Intrathecal drug delivery (IDD) is a well-established treatment modality for refractory chronic pain. Intrathecal catheter-tip granuloma (ICTG) formation is a known possible complication of opiate IDD and is likely triggered by mast cell degranulation. The use of low concentration and dosage of opioids that do not induce mast cell degranulation has been advised to mitigate the risk of ICTG formation.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate whether adding 20 μg of naloxone to a fentanyl-bupivacaine mixture would decrease pruritis (itchiness) in pregnant females undergoing cesarean sections (CS).
  • Eighty pregnant patients were randomly assigned to receive either just the fentanyl-bupivacaine mixture (group F) or the mixture plus naloxone (group FN), with the incidence and characteristics of pruritis being measured.
  • Results showed that the group receiving naloxone experienced significantly less pruritis, with later onset, shorter duration, and less severity, while their postoperative pain management outcomes remained similar to those who did not receive naloxone.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!